Počet záznamů: 1  

Structural changes of sodium warfarin in tablets affecting the dissolution profiles and potential safety of generic substitution

  1. 1.
    0545620 - ÚMCH 2022 RIV CH eng J - Článek v odborném periodiku
    Muselík, J. - Urbanová, Martina - Bartoníčková, E. - Palovčík, J. - Vetchý, D. - Czernek, Jiří - Janisova, Larisa - Velychkivska, Nadiia - Franc, A. - Brus, Jiří
    Structural changes of sodium warfarin in tablets affecting the dissolution profiles and potential safety of generic substitution.
    Pharmaceutics. Roč. 13, č. 9 (2021), č. článku 1364. E-ISSN 1999-4923
    Grant CEP: GA MŠMT(CZ) LTAUSA18011
    Výzkumná infrastruktura: e-INFRA CZ - 90140; ELIXIR-CZ - 90047
    Institucionální podpora: RVO:61389013
    Klíčová slova: warfarin * solid-state NMR * polymorphism
    Obor OECD: Physical chemistry
    Impakt faktor: 6.525, rok: 2021
    Způsob publikování: Open access
    https://www.mdpi.com/1999-4923/13/9/1364

    At present, the risk of generic substitutions in warfarin tablets is still being discussed. The aim of this study was to assess whether API interactions with commonly used excipients may affect the safety of generic replacement of warfarin sodium tablets. These interactions were observed during an accelerated stability study, and the effect of the warfarin solid phase (crystalline/amorphous form) as well as the API particle size distribution was studied. Commercial tablets and prepared tablets containing crystalline warfarin or amorphous warfarin were used. In addition, binary mixtures of warfarin with various excipients were prepared. The structural changes before and after the stability study were monitored by dissolution test in different media, solid-state NMR spectroscopy and Raman microscopy. During the stability study, the conversion of the sodium in warfarin to its acid form was demonstrated by some excipients (e.g., calcium phosphate). This change in the solid phase of warfarin leads to significant changes in dissolution, especially with the different particle sizes of the APIs in the tablet. Thus, the choice of suitable excipients and particle sizes are critical factors influencing the safety of generic warfarin sodium tablets.
    Trvalý link: http://hdl.handle.net/11104/0322298

     
     
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.